Multiomics Analysis Reveals CTHRC1+ CAFs Drive Immunosuppressive Niches and Predict Immunotherapy Resistance in Gastric Cancer
Human Mutation · 2026-01 · 2026 (1)
DOI: 10.1155/humu/2370955 ↗Kurz gefasst
Fachartikel in der Zeitschrift Human Mutation, online erschienen am 18.07.2026. Verfasst von Yingxin Wu und 7 weiteren Autor:innen. Beteiligte Einrichtung: Section for Gastrointestinal Surgery, Department of General Surgery, The Third People's Hospital of Chengdu, Chengdu, Sichuan, China. Hauptthemen laut MEDLINE: Stomach Neoplasms, Cancer-Associated Fibroblasts, Immunotherapy, Extracellular Matrix Proteins. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Cancer‐associated fibroblasts (CAFs) orchestrate immune‐excluded tumor microenvironment (TME), but the CAF heterogeneity remains incompletely understood in gastric cancer (GC). In this study, we integrated multicohort single‐cell RNA sequencing (scRNA‐seq), spatial transcriptomics, and bulk transcriptomic data to construct a comprehensive atlas of the GC TME. Unsupervised clustering identified eight transcriptionally distinct CAF subpopulations, among which CTHRC1+ CAFs were selectively enriched in tumors and showed the strongest association with T cell exclusion. Pseudotemporal trajectory analysis, gene regulatory network inference, and cell–cell communication analysis revealed that basic helix‐loop‐helix family member e41 (BHLHE41) serves as a key transcription factor driving CTHRC1+ CAF differentiation, whereas spatial analyses demonstrated these fibroblasts contribute to fibrotic niches at the tumor–stroma interface through macrophage migration inhibitory factor (MIF)–mediated signaling. Finally, we developed and validated a CTHRC1+ cancer‐associated fibroblast–related risk signature (CRS) that accurately predicts immunotherapy response across independent cohorts. These findings establish CTHRC1+ CAFs as a critical stromal determinant of immune exclusion in GC, suggesting that targeting the CTHRC1+ CAF‐MIF axis or applying CRS‐guided patient stratification may enhance immunotherapy efficacy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Section for Gastrointestinal Surgery, Department of General Surgery, The Third People's Hospital of Chengdu, Chengdu, Sichuan, China.
- Department of General Surgery, Fujian Medical University Union Hospital, Fuzhou, Fujian, China, fjmu.edu.cn.
- Key Laboratory of Ministry of Education of Gastrointestinal Cancer, Fujian Medical University, Fuzhou, Fujian, China, fjmu.edu.cn.
- Department of Gastrointestinal Surgery, Clinical Medical College and The First Affiliated Hospital of Chengdu Medical College, Chengdu, Sichuan, China.
ORCID-Profile: Yingxin Wu, Ping Li, Jianwei Xie, Chaohui Zheng, Changming Huang, Hua-Ping Ye, Yan-Jun Liu
Zitieren
APA
Wu, Y., Tang, L. H., Li, P., Xie, J., Zheng, C., Huang, C., Ye, H. P., & Liu, Y. J. (2026). Multiomics Analysis Reveals CTHRC1+ CAFs Drive Immunosuppressive Niches and Predict Immunotherapy Resistance in Gastric Cancer. Human Mutation, 2026(1). https://doi.org/10.1155/humu/2370955
Vancouver
Wu Y, Tang LH, Li P, Xie J, Zheng C, Huang C, et al. Multiomics Analysis Reveals CTHRC1+ CAFs Drive Immunosuppressive Niches and Predict Immunotherapy Resistance in Gastric Cancer. Human Mutation. 2026;2026(1). doi:10.1155/humu/2370955
BibTeX
@article{Wu2026,
author = {Wu, Yingxin and Tang, Ling-Han and Li, Ping and Xie, Jianwei and Zheng, Chaohui and Huang, Changming and Ye, Hua-Ping and Liu, Yan-Jun},
title = {Multiomics Analysis Reveals CTHRC1+ CAFs Drive Immunosuppressive Niches and Predict Immunotherapy Resistance in Gastric Cancer},
journal = {Human Mutation},
year = {2026},
volume = {2026},
number = {1},
doi = {10.1155/humu/2370955}
}
EUVIMED